News
A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway ...
With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent ...
Daniel Drucker, Ozempic’s father: ‘I’m very conservative. I don’t sell the drugs. I study the drugs’
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...
As GLP-1-based drugs like semaglutide gain popularity, new insights highlight how gut health, diet, protein, and sleep can ...
With their lengthening laundry list of health benefits, drugs like Ozempic are showing promise for people who struggle with addiction.
Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results